Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies


“Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies”

This report presents an in-depth assessment of the top 20 vaccine companies' market dynamics, opportunities, competitive landscape and discusses major trends.

The report offers the most up-to-date top 20 vaccine companies market data from 2015 to 2019. A comprehensive analysis has been done on market share and ranking with the percentage of all the leading 20 vaccine companies. The report also provides a detailed description of growth drivers and inhibitors of the vaccine market. Key trends in terms of collaboration and partnership deals, merger and acquisition, distribution, exclusive, and licensing agreements are analyzed with details. 

The report concludes with the profiles of the top 20 vaccine companies in the vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines market value analysis, and strategic development.

The Top 20 Leading Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:

• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Merck & Co., Inc.
• Pfizer
• AstraZeneca
• Mitsubishi Tanabe Pharma
• Emergent BioSolutions
• Astellas Pharma Inc.
• Valneva
• Seqirus(CSL Limited)
• Bavarian Nordic
• Sinovac
• Panacea Biotec
• Dynavax Technologies Corporation
• Bharat Biotech
• Serum Institute of India
• Biological E. Limited
• Grifols
• Hualan Biological Engineering Inc
• Gamma Vaccines Pty Ltd

Report Scope:

• The Total Market Value of the Top 20 Vaccine Companies 
• Top 20 Vaccine Companies Market Share and Ranking in the Vaccines Market 
• Investigates the Key Growth Drivers and Restraints of the Vaccines Market
• Provides Key Trends with Respect to Collaborations, Partnerships, Merger and Acquisitions, Distribution, Exclusive and Licensing Agreement
• In-depth Assessment of the Top 20 Vaccine Companies Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Market Value Analysis, and Strategic Development

Key Questions Answered in this Market Research Report:

• Who are the top 20 leading companies in the vaccine market?
• What is the top leading companies’ strategic development?
• Which company has the highest market share in the vaccine market?
• How many vaccines are in clinical development by the top leading companies?
• What is the vaccine market value of the top leading companies?
• How many vaccines available in the marketby the top leading companies?
• What are the major drivers of the vaccine market?
• What are the major inhibitors of the vaccine market?
• What are the major deals happenings in the vaccine market?
• What is the competitive landscape in the vaccine market?
1. Executive Summary

2. Global Total Market Value of the Top 20 Vaccine Companies (2015 – 2019) 

3. Market Share Analysis of the Top 20 Vaccine Companies (%)

4. Key Market Drivers and Inhibitors in the Vaccine Market
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. Major Deals and Agreement Happenings in the Vaccine Market
5.1 Merger & Acquisitions
5.2 Collaboration Deals
5.3 Licensing Agreement
5.4 Exclusive Agreement
5.5 Distribution Agreement
5.6 Partnership Deals

6. Top 20 Vaccine Companies in the Vaccine Market
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Vaccines Portfolio
6.1.3 Vaccines Market Value Analysis
6.1.4 Promising Vaccines in the Clinical Development
6.1.5 Recent Development
6.2 GlaxoSmithKline (GSK) 
6.2.1 Business Overview
6.2.2 Vaccines Portfolio
6.2.3 Vaccines Market Value Analysis
6.2.4 Promising Vaccines in the Clinical Development
6.2.5 Recent Development
6.3 Merck & Co., Inc. 
6.3.1 Business Overview
6.3.2 Vaccines Portfolio
6.3.3 Vaccines Market Value Analysis
6.3.4 Promising Vaccines in the Clinical Development
6.3.5 Recent Development
6.4 Pfizer
6.4.1 Business Overview
6.4.2 Vaccines Portfolio
6.4.3 Vaccines Market Value Analysis
6.4.4 Promising Vaccines in the Clinical Development
6.4.5 Recent Development
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Vaccines Portfolio
6.5.3 Vaccines Market Value Analysis
6.5.4 Recent Development
6.6 Mitsubishi Tanabe Pharma
6.6.1 Business Overview
6.6.2 Vaccines Portfolio
6.6.3 Vaccines Market Value Analysis
6.6.4 Promising Vaccines in the Clinical Development
6.6.5 Recent Development
6.7 Emergent BioSolutions
6.7.1 Business Overview
6.7.2 Vaccines Portfolio
6.7.3 Vaccines Market Value Analysis
6.7.4 Promising Vaccines in the Clinical Development
6.7.5 Recent Development
6.8 Astlellas Pharma Inc
6.8.1 Business Overview
6.8.2 Vaccines Portfolio
6.8.3 Vaccines Market Value Analysis
6.8.4 Recent Development
6.9 Valneva
6.9.1 Business Overview
6.9.2 Vaccines Portfolio
6.9.3 Vaccines Market Value Analysis
6.9.4 Promising Vaccines in the Clinical Development
6.9.5 Recent Development
6.10 Seqirus (CSL Limited) 
6.10.1 Business Overview
6.10.2 Vaccines Portfolio
6.10.3 Vaccines Market Value Analysis
6.10.4 Promising Vaccines in the Clinical Development
6.10.5 Recent Development
6.11 Bavarian Nordic
6.11.1 Business Overview
6.11.2 Vaccines Portfolio
6.11.3 Vaccines Market Value Analysis
6.11.4 Promising Vaccines in the Clinical Development
6.11.5 Recent Development
6.12 Sinovac
6.12.1 Business Overview
6.12.2 Vaccines Portfolio
6.12.3 Vaccines Market Value Analysis
6.12.4 Promising Vaccines in the Clinical Development
6.12.5 Recent Development
6.13 Panacea Biotec
6.13.1 Business Overview
6.13.2 Vaccines Portfolio
6.13.3 Vaccines Market Value Analysis
6.13.4 Promising Vaccines in the Clinical Development
6.13.5 Recent Development
6.14 Dynavax Technologies Corporation
6.14.1 Business Overview
6.14.2 Vaccines Portfolio
6.14.3 Vaccines Market Value Analysis
6.14.4 Promising Vaccines in the Clinical Development
6.14.5 Recent Development
6.15 Bharat Biotech
6.15.1 Business Overview
6.15.2 Vaccines Portfolio
6.15.3 Promising Vaccines in the Clinical Development
6.15.4 Recent Development
6.16 Serum Institute of India
6.16.1 Business Overview
6.16.2 Vaccines Portfolio
6.16.3 Promising Vaccines in Clinical Development
6.16.4 Recent Development
6.17 Biological E. Limited
6.17.1 Business Overview
6.17.2 Vaccines Portfolio
6.17.3 Promising Vaccines in the Clinical Development
6.17.4 Recent Development
6.18 Grifols
6.18.1 Business Overview
6.18.2 Vaccines Portfolio
6.18.3 Recent Development
6.19 Hualan Biological Engineering Inc
6.19.1 Business Overview
6.19.2 Influenza Vaccines Portfolio
6.19.3 Recent Development
6.20 Gamma Vaccines Pty Ltd
6.20.1 Business Overview
6.20.2 Influenza Vaccines Portfolio
6.20.3 Recent Development

List of Tables: Table 5–1: Merger & Acquisitions in the Vaccine Market Table 5–2: Collaboration Deals in the Vaccine Market Table 5–3: Licensing Agreement in the Vaccine Market Table 5–4: Exclusive Agreement in the Vaccine Market Table 5–5: Distribution Agreement in the Vaccine Market Table 5–6: Partnership Deals in the Vaccine Market Table 6–1: Sanofi Promising Vaccines in the Clinical Development Table 6–2: GSK Promising Vaccines in the Clinical Development Table 6–3: Merck Promising Vaccines in the Clinical Development Table 6–4: Pfizer Promising Vaccines in the Clinical Development Table 6–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development Table 6–6: Emergent Biosolutions Promising Vaccines in the Clinical Development Table 6–7: Valneva Promising Vaccines in the Clinical Development Table 6–8: Seqirus Promising Vaccines in the Clinical Development Table 6–9: Bavarian Nordic Promising Vaccines in the Clinical Development Table 6–10: Sinovac Promising Vaccines in the Clinical Development Table 6–11: Panacea Biotec Promising Vaccines in the Clinical Development Table 6–12: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development Table 6–13: Bharat Biotech Promising Vaccines in the Clinical Development List of Figures: Figure 2–1: Global Top 20 Vaccine Companies Sales Value (Million US$),2015 – 2019 Figure 3–1: Market Share Analysis of the Top 20 Vaccine Companies (Percent), 2019 Figure 6–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–2: GSK Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–3: Merck Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–4: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–5: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–6: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–7: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–8: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–9: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–10: Seqirus Vaccines Market Value Analysis (Million US$),2015 - 2019 Figure 6–11: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–12: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–13: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–14: Dynavax Vaccines Market Value Analysis (Million US$),2018 – 2019

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by DPI Research

Cancer Vaccines Market, Pipeline Analysis Report 2020

a??Global Cancer Vaccines market size is expected to surpass US$ 8.5 Billion by 2025a?? Report Scope: a?? Detailed Insights of the Introduction to Cancer Vaccines and Mechanism of Cancer Vaccines a?? The Market Size of the Global Cancer Vaccines Mar...

Impact of COVID-19 Outbreak on Indian Outbound Travelers Traffic and Market Revenue to the GCC (United Arab Emirates (UAE), Saudi Arabia, Oman, Qatar, Kuwait, and Bahrain) Countries

It is forecasted that GCC countries will attract nearly 7.7 Million Indian travelers and generated more than US$ 12 billion market revenues by 2025. The objective of this market research report is to provide an overview of the development of the Ind...

Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026

Worldwide Diabetes Reusable Insulin Delivery Pen Market size is expected to touch US$ 6 billion by 2026. The following factors are likely to contribute to the growth of the diabetes reusable insulin delivery pen market during the forecast period: ...

Worldwide Diabetes Disposable Insulin Delivery Pen Market Prospect, Share, Development, Growth & Demand Forecast to 2026

Worldwide Diabetes Disposable Insulin Delivery Pen Market size is anticipated to exceed USD 14 billion by 2026. The objective of this market research report is to provide a comprehensive analysis of the fast-evolving, high-growth worldwide diabetes ...

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

“Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies” This report presents an in-depth assessme...

Publisher: DPI Research
Chat with us